Navigation Links
Popular Nevil and Reeferman Medical Marijuana Seeds Now Available From R.M.S.S. Medical Marijuana Seed Sales
Date:8/29/2013

NEW YORK, Aug, 29, 2013 /PRNewswire-iReach/ -- British Columbia's leading medical marijuana seed provider R.M.S.S. Medical Marijuana seeds, is proud to announce that they are now offering one of the largest selections of the ever-popular Reeferman medical marijuana seeds and Nevil medical marijuana seeds online. Many believe that Reeferman seeds are the best medical marijuana seeds on the planet and the legendary Reeferman seeds recently won the High Times Cannabis Cup Award. R.M.S.S. also carries a giant selection of some of the most popular medical marijuana seeds including strains from many of the world's top producers.

(Photo:  http://photos.prnewswire.com/prnh/20130829/MN71136)

R.M.S.S. offers one of the largest selections of Nevil medical marijuana seeds in the world. Their massive selection includes many of Nevil's newest and most popular strains. The brand new strains from the breeder of the legendary Nevil's Haze are in stock and ready to ship immediately. R.M.S.S.'s giant selection of Nevil seeds includes strains such as Mad Kush, Northern Lights Skink, Mowie Gold X Skunk, G13 Chem Dog, Chemo (ubc cut), Cup Winner, and Golden Temple Kish

R.M.S.S. is one of the leading suppliers of Reeferman medical marijuana seeds. Their selection of Reeferman seeds is second to none and includes such popular strains as Master Kish, bubble gum chronic, King, Kings Crown, and many many more.

Reeferman seeds are known for their high quality and have received many award including:

2010 Treating yourself cup 1st place Compassion Club early Purple Kush 3rd place Ultra King
2006 High-Life cup Amsterdam Best Indica Pink Kush
2006 Battle of the bridges NYC 1st Place Love Potion
2005 High-Times Cannabis cup 1st place coffee shop Barney's/Reeferman Willie Nelson
2005 IC Mag 1st place Hashish Kings Kross Bubble
2004 Reeferman Seeds won the Seed Company Sativa Cup for its Love Potion #1 strain

For more information about R.M.S.S.'s giant selection of medical marijuana seeds or to purchase Nevil or Reeferman seeds contact R.M.S.S. by visiting their website at http://medicinalmarijuanaseedssales.co.uk or by calling them toll free at (855) 425-3437

Media Contact: Media Relations, On Call News, (424) 281-4059, mediarelations@oncallnews.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE R.M.S.S. Medical Marijuana seeds
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Report Examines Efforts to Reduce the Impact of Generic Competition for Popular Drug Lipitor
2. NEW POLL: Tennessee Voters Strongly Oppose Making Popular Cold and Allergy Meds Prescription Only
3. Software Most Popular Sector For European Venture Investment In Third Quarter This Year
4. Health-Conscious Women are Sixty Percent More Likely to Prefer Popular Brand-Name Drugs, Even if They Cost More
5. ClosedWon Launches QuickQuote at Dreamforce 2012 on Salesforce.coms AppExchange, the Worlds Most Popular Cloud Marketplace for Social Apps for Business
6. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
7. New Strains of Nevil and ReeferMan Medical Marijuana Seeds Now Available Online From R.M.S.S. Medical Marijuana Seed Sales
8. Reeferman Medical Marijuana Seeds Now Available from R.M.S.S.
9. Fighting Failed Back Surgery with Laser Treatment at California Orthopaedic Medical Clinic
10. MEMS in Medical Applications Market is Expected to Reach USD 6.5 Billion Globally in 2019: Transparency Market Research
11. National coordinated health care and health IT transformation event will be hosted by OCHIN, Inc., the Oregon Medical Association, and Oregon Health Network: The cHealth Innovation Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):